GeneCentric

GeneCentric is a precision oncology company focused on enhancing cancer diagnostics and genomic profiling through gene expression analysis. The company aims to meet the needs in precision oncology by developing advanced biomarkers for blood testing.

Founded on extensive gene expression research, GeneCentric has created proprietary technology that allows for inferring gene expression from standard circulating tumor DNA (ctDNA) sequencing. Their primary offering, the GenomicsNext™ platform, is a multimodal liquid biopsy solution that detects DNA alterations and inferred gene expression from a single blood sample. This platform utilizes the ExpressCT™ technology to identify DNA regions closely associated with tissue expression.

In addition to its platform, GeneCentric conducts GenomicsNext Research Studies, providing liquid biopsy testing for genomics research. The company collaborates with leading research organizations, biopharmaceutical companies, and commercial laboratories to develop tailored solutions that leverage gene expression signatures.